Post by PharmaShots

Otsuka Pharmaceutical Co., Ltd. reports P-IIIb results for centanafadine in adults with ADHD and comorbid anxiety, achieving significant improvements in both ADHD symptoms and anxiety scores versus placebo Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #otsuka #piiib #clinicaltrial #centanafadine #adhd #comorbidanxiety #priorityreview #pdufa #cns #psychiatry #neurology #mentalhealth https://lnkd.in/g4vYeM5i